Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37


Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.

Waghmare A, Wagner T, Andrews R, Smith S, Kuypers J, Boeckh M, Moss R, Englund JA.

J Pediatric Infect Dis Soc. 2015 Jun;4(2):114-8. doi: 10.1093/jpids/piu039. Epub 2014 May 14.


Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies.

Seo S, Renaud C, Kuypers JM, Chiu CY, Huang ML, Samayoa E, Xie H, Yu G, Fisher CE, Gooley TA, Miller S, Hackman RC, Myerson D, Sedlak RH, Kim YJ, Fukuda T, Fredricks DN, Madtes DK, Jerome KR, Boeckh M.

Blood. 2015 Jun 11;125(24):3789-97. doi: 10.1182/blood-2014-12-617035. Epub 2015 Apr 27.


Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Chemaly RF, Shah DP, Boeckh MJ.

Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S344-51. doi: 10.1093/cid/ciu623. Review.


Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.

Palmer SG, DeVito I, Jenkins SG, Niewiesk S, Porotto M, Moscona A.

J Virol. 2014 Nov;88(22):13495-502. doi: 10.1128/JVI.01965-14. Epub 2014 Sep 10.


Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes.

Seo S, Xie H, Karron RA, Thumar B, Englund JA, Leisenring WM, Stevens-Ayers T, Boeckh M, Campbell AP.

Bone Marrow Transplant. 2014 Sep;49(9):1205-11. doi: 10.1038/bmt.2014.124. Epub 2014 Jun 30.


Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome.

Seo S, Xie H, Campbell AP, Kuypers JM, Leisenring WM, Englund JA, Boeckh M.

Clin Infect Dis. 2014 May;58(10):1357-68. doi: 10.1093/cid/ciu134. Epub 2014 Mar 5.


DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation.

Chalkias S, Mackenzie MR, Gay C, Dooley C, Marty FM, Moss RB, Li T, Routh RL, Walsh SR, Tan CS.

Transpl Infect Dis. 2014 Feb;16(1):141-4. doi: 10.1111/tid.12177. Epub 2014 Jan 3.


Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.

Lin R, Liu Q.

J Hematol Oncol. 2013 Dec 17;6:94. doi: 10.1186/1756-8722-6-94. Review.


Human parainfluenza virus type 3 in wild nonhuman primates, Zambia.

Sasaki M, Ishii A, Orba Y, Thomas Y, Hang'ombe BM, Moonga L, Mweene AS, Ogawa H, Nakamura I, Kimura T, Sawa H.

Emerg Infect Dis. 2013;19(9). doi: 10.3201/eid1909.121404.


Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.

Renaud C, Xie H, Seo S, Kuypers J, Cent A, Corey L, Leisenring W, Boeckh M, Englund JA.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1220-6. doi: 10.1016/j.bbmt.2013.05.005. Epub 2013 May 13.


Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.

Mason JN, Elbahesh H, Russell CJ.

J Virol. 2013 May;87(10):5959-69. doi: 10.1128/JVI.00227-13. Epub 2013 Mar 20.


Respiratory viral infections after hematopoietic stem cell transplantation in children.

Choi JH, Choi EH, Kang HJ, Park KD, Park SS, Shin HY, Lee HJ, Ahn HS.

J Korean Med Sci. 2013 Jan;28(1):36-41. doi: 10.3346/jkms.2013.28.1.36. Epub 2013 Jan 8.


Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.

Park SY, Baek S, Lee SO, Choi SH, Kim YS, Woo JH, Sung H, Kim MN, Kim DY, Lee JH, Lee JH, Lee KH, Kim SH.

Antimicrob Agents Chemother. 2013 Feb;57(2):983-9. doi: 10.1128/AAC.01961-12. Epub 2012 Dec 10.


Management of respiratory viral infections in hematopoietic cell transplant recipients.

Shah DP, Ghantoji SS, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF.

Am J Blood Res. 2012;2(4):203-18. Epub 2012 Nov 25.


Using antimicrobial adjuvant therapy in cancer treatment: a review.

Alibek K, Bekmurzayeva A, Mussabekova A, Sultankulov B.

Infect Agent Cancer. 2012 Nov 20;7(1):33. doi: 10.1186/1750-9378-7-33.


Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus.

Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P.

Clin Infect Dis. 2013 Jan;56(2):258-66. doi: 10.1093/cid/cis844. Epub 2012 Sep 28. Review.


Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.

Ustun C, SlabĂ˝ J, Shanley RM, Vydra J, Smith AR, Wagner JE, Weisdorf DJ, Young JA.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1580-8. doi: 10.1016/j.bbmt.2012.04.012. Epub 2012 Apr 21.


Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Weigt SS, Gregson AL, Deng JC, Lynch JP 3rd, Belperio JA.

Semin Respir Crit Care Med. 2011 Aug;32(4):471-93. doi: 10.1055/s-0031-1283286. Epub 2011 Aug 19. Review.


Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.

Renaud C, Campbell AP.

Curr Opin Infect Dis. 2011 Aug;24(4):333-43. doi: 10.1097/QCO.0b013e3283480440. Review.


Parainfluenza virus infections in children with hematologic malignancies.

Srinivasan A, Wang C, Yang J, Inaba H, Shenep JL, Leung WH, Hayden RT.

Pediatr Infect Dis J. 2011 Oct;30(10):855-9. doi: 10.1097/INF.0b013e31821d190f.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk